Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.26% | 80.04 | 0.9% | $592.67m | |
| CELG | Celgene Corporation | -1.35% | 136.98 | 1.1% | $550.87m | |
| AMGN | Amgen Inc. | -0.08% | 186.05 | 1.1% | $449.49m | |
| BIIB | Biogen Inc. | 0.22% | 345.23 | 1.2% | $387.34m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.30% | 436.83 | 2.7% | $313.83m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -1.94% | 116.40 | 10.7% | $251.34m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.38% | 154.47 | 1.9% | $220.62m | |
| INCY | Incyte Corporation | -0.37% | 115.21 | 2.5% | $207.20m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.92% | 140.41 | 1.9% | $178.54m | |
| ILMN | Illumina, Inc. | -0.23% | 206.01 | 3.5% | $139.56m | |
| EXEL | Exelixis, Inc. | -1.87% | 27.77 | 6.5% | $132.90m | |
| CLVS | Clovis Oncology, Inc. | -2.42% | 79.35 | 16.5% | $121.66m | |
| BLUE | Bluebird Bio, Inc. | -1.23% | 138.48 | 17.3% | $116.67m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.18% | 51.63 | 16.9% | $109.83m | |
| BMRN | BioMarin Pharmaceutical Inc. | -4.43% | 89.40 | 4.4% | $98.91m |
Company Profile
Arbutus Biopharma Corp. is a biopharmaceutical company. It focuses on discovering, developing and commercializing a cure for patients suffering from chronic HBV infection, a liver disease caused by the hepatitis B virus. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.